Millennium Biotechnologies develops new novel line extensions of Resurgex Select(R)

14/02/06 Millennium Biotechnologies, Inc., a wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (MBTG), is announcing the development of new, unique line extensions of its successful Resurgex Select(R) line of products. In addition to their flagship, versatile beverage formula, delicious confectionary bars and refreshing freeze pop line extensions directed at addressing the nutritional needs of the oncology patient during treatment.

It is imperative to eat well while receiving treatment for cancer. A diet high in quality calories aimed at supporting healthy weight is essential for positive treatment outcomes. Unfortunately, loss of appetite, depression and fatigue interfere with adequate nutritional intake. In addition, side effects of chemo and radiation therapy including nausea and mouth and throat problems, may make it difficult or painful to eat and in many cases for extended periods of time. Eating small meals or snacks, alternating solid foods and beverages and varying the diet are some of the important measures a patient can take to assure adequate nutritional intake.

In addition to the providing choices and alternatives to the typical ready to drink formulations on the market, Millennium Biotechnologies understands that the life blood of any company is new product entries and nurturing successful branded products with line extensions. Hence, the development of their new unique dosage formats aimed to enhance patient acceptance, adherence and compliance to their Resurgex(R) products.